Silver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53

Papers of special note have been highlighted as: ▪ of interest

References

• 1  Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J. Clin.57(1),43–66 (2007).
  MedlineGoogle Scholar
• 2  Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie S, O’Regan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol.7(8),657–667 (2006).
  Medline CASGoogle Scholar
• 3  Murphy CJ, Gole AM, Stone JW et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc. Chem. Res.41(12),1721–1730 (2008).
  Medline CASGoogle Scholar
• 4  Tiwari SB, Amiji MM. A review of nanocarrier-based CNS delivery systems. Curr. Drug Deliv.3(2),219–232 (2006).
  Medline CASGoogle Scholar
• 5  Lee KJ, Nallathamby PD, Browning LM, Osgood CJ, Xu XH. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano1(2),133–143 (2007).
  Medline CASGoogle Scholar
• 6  Huang T, Nallathamby PD, Xu XH. Photostable single-molecule nanoparticle optical biosensors for real-time sensing of single cytokine molecules and their binding reactions. J. Am. Chem. Soc.130(50),17095–17105 (2008).
  Medline CASGoogle Scholar
• 7  Agrawal A, Sathe T, Nie S. Nanoparticle probes for ultrasensitive biological detection and imaging. In: New Frontiers in Ultrasensitive Bioanalysis: Advanced Analytical Chemistry Applications in Nanobiotechnology, Single Molecule Detection, and Single Cell Analysis. Xu X-HN (Ed.). Wiley, NY, USA, 71–89 (2007).
  Google Scholar
• 8  Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnology8,1 (2010).
  MedlineGoogle Scholar
• 9  Morones JR, Elechiguerra JL, Camacho A et al. The bactericidal effect of silver nanoparticles. Nanotechnology16(10),2346–2353 (2005).
  Medline CASGoogle Scholar
• 10  Mohanty S, Mishra S, Jena P, Jacob B, Sarkar B, Sonawane A. Investigation on antibacterial, cytotoxic and antibiofilm efficacy of starch stabilized silver nanoparticle. Nanomedicine8(6),916–924 (2012).▪ One of the first reports investigating the antiproliferative properties of silver-based nanoparticles.
  Medline CASGoogle Scholar
• 11  Asharani PV, Hande MP, Valiyaveettil S. Anti-proliferative activity of silver nanoparticles. BMC Cell Biol.10,65 (2009).▪ One of the first reports investigating the anti-tumor activity of silver-based nanoparticles.
  Medline CASGoogle Scholar
• 12  Sriram MI, Kanth SB, Kalishwaralal K, Gurunathan S. Anti-tumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int. J. Nanomedicine5,753–762 (2010).
  Medline CASGoogle Scholar
• 13  Sanpui P, Chattopadhyay A, Ghosh SS. Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl. Mater. Interfaces3(2),218–228 (2011).
  Medline CASGoogle Scholar
• 14  Nallathamby PD, Xu XH. Study of cytotoxic and therapeutic effects of stable and purified silver nanoparticles on tumor cells. Nanoscale2(6),942–952 (2010).
  Medline CASGoogle Scholar
• 15  Bryaskova R, Pencheva D, Nikolov S, Kantardjiev T. Synthesis and comparative study on the antimicrobial activity of hybrid materials based on silvernanoparticles (AgNps) stabilized by polyvinylpyrrolidone (PVP). J. Chem. Biol.4(4),185–191 (2011).
  MedlineGoogle Scholar
• 16  Shameli K, Ahmad MB, Jazayeri SD et al. Synthesis and characterization of polyethylene glycol mediated silver nanoparticles by the green method. Int. J. Mol. Sci.13(6),6639–6650 (2012).
  Medline CASGoogle Scholar
• 17  Deepak KL, Kuladeep R, Alee KS, Rao DN. Synthesis of silver nanoparticles in poly(vinyl alcohol) matrix in solution and thin films through laser irradiation. J. Nanosci. Nanotechnol.12(2),920–927 (2012).
  Medline CASGoogle Scholar
• 18  Silva AR, Unali G. Controlled silver delivery by silver-cellulose nanocomposites prepared by a one-pot green synthesis assisted by microwaves. Nanotechnology22(31),315605 (2011).
  MedlineGoogle Scholar
• 19  Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A. Toxicity and antibacterial assessment of chitosancoated silver nanoparticles on human pathogens and macrophage cells. Int. J. Nanomedicine7,1805–1818 (2012).
  Medline CASGoogle Scholar
• 20  Raveendran P, Fu J, Wallen SL. Completely ‘green’ synthesis and stabilization of metal nanoparticles. J. Am. Chem. Soc.125,13940–13941 (2003).
  Medline CASGoogle Scholar
• 21  Asharani PV, Lianwu Y, Gong Z, Valiyaveettil S. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology5(1),43–54 (2011).
  Medline CASGoogle Scholar
• 22  Asharani PV, Lian WuY, Gong Z, Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology19,255102 (2008).
  Medline CASGoogle Scholar
• 23  Bunz F, Hwang PM, Torrance C et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Invest.104(3),263–269 (1999).
  Medline CASGoogle Scholar
• 24  Ahmad A, Mukherhjee P, Senapati S et al. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf. B28,313 (2003).
  CASGoogle Scholar
• 25  Thomas S, Nair SK, Jamal EMA, Al-Harthi HS, Varma MR, Anantharaman MR. Size dependant surface plasmon resonance in silica silver nanocomposites. Nanotechnology19(7),075710 (2008).
  MedlineGoogle Scholar
• 26  Vigneshwaran N, Nachane RP, Balasubramanya RH, Varadarajan PV. A novel one-pot ‘green’ synthesis of stable silver nanoparticles using soluble starch. Carbohydr. Res.341(12),2012–2018 (2006).
  Medline CASGoogle Scholar
• 27  Buban JP, Ramasse Q, Gipson B, Browning ND, Stahlberg H. High-resolution low-dose scanning transmission electron microscopy. J. Electron Microsc. (Tokyo)59(2),103–112 (2010).
  Medline CASGoogle Scholar
• 28  Preet R, Mohapatra P, Mohanty S et al. Quinacrine has anti-cancer activity in breast cancer cells through inhibition of topoisomerase activity. Int. J. Cancer130(7),1660–1670 (2012).
  Medline CASGoogle Scholar
• 29  Mohapatra P, Preet R, Choudhuri M, Choudhuri T, Kundu CN. 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells. Oncol. Res.19(7),311–321 (2011).▪ First report on single-cell gel electrophoresis.
  MedlineGoogle Scholar
• 30  Tice RR, Agurell E, Anderson D et al. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen.35(3),206–221 (2000).▪ One of the first reports examining the p53-mediated anticancer properties of silver-based nanoparticles.
  Medline CASGoogle Scholar
• 31  Gopinath P, Gogoi SK, Sanpui P, Paul A, Chattopadhyay A, Ghosh SS. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloids Surf. B. Biointerfaces77(2),240–245 (2010).
  Medline CASGoogle Scholar
• 32  Asharani P, Sethu S, Lim HK, Balaji G, Valiyaveettil S, Hande MP. Differential regulation of intracellular factors mediating cell cycle, DNA repair and inflammation following exposure to silver nanoparticles in human cells. Genome Integr.3(1),2 (2012).
  Medline CASGoogle Scholar
• 33  Roth BL, Sheffler DJ, Kroeze WK. Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat. Rev. Drug Discov.3(4),353–359 (2004).
  Medline CASGoogle Scholar
• 34  Hopkins AL, Mason JS, Overington JP. Can we rationally design promiscuous drugs? Curr. Opin. Struct. Biol.16(1),127–136 (2006).
  Medline CASGoogle Scholar
• 35  Sivachenko A, Kalinin A, Yuryev A. Pathway analysis for design of promiscuous drugs and selective drug mixtures. Curr. Drug Discov. Technol.3(4),269–277 (2006).
  Medline CASGoogle Scholar
• 36  Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat. Rev. Drug Discov.5(12),993–996 (2006).
  Medline CASGoogle Scholar
• 37  Brown CJ, Lain S, Verma CS, Fersht AR, Lane DP. Awakening guardian angels: drugging the p53 pathway. Nat. Rev. Cancer9(12),862–873 (2009).
  Medline CASGoogle Scholar
• 38  Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol.5(10),749–759 (2005).
  Medline CASGoogle Scholar
• 39  Tergaonkar V, Perkins ND. p53 and NF-κB crosstalk: IKKalpha tips the balance. Mol. Cell.26(2),158–159 (2007).
  Medline CASGoogle Scholar